Table 3

Changes in clinical outcomes from EMR before and after threshold in RA-CUSUM curve analysis for patients with cancer by (A) annual endoscopist volume and (B) annual hospital volume

VariableVolume threshold per yearOverall rateBelowAbovep Value
Endoscopist annual volume
 Emergency intervention1 case0.6% (0.3% to 1.3%)1.8% (0.8% to 3.9%)0.1% (0.0% to 0.7%)0.002
 30-day mortality2 cases3.1% (2.2% to 4.3%)6.1% (4.3% to 8.5%)0.4% (0.1% to 1.3%)<0.001
 90-day mortality2 cases6.8% (5.4% to 8.4%)12.0% (9.4% to 15.1%)2.1% (1.2% to 3.7%)<0.001
 Re-intervention8 cases23.6% (21.1% to 26.8%)24.2% (21.1% to 27.3%)17.5% (13.5% to 22.2%)0.033
Hospital annual volume
 Emergency intervention5 cases0.6% (0.3% to 1.3%)1.6% (0.7% to 3.6%)0.3% (0.1% to 1.0%)0.016
 30-day mortality8 cases3.1% (2.2% to 4.3%)5.3% (3.6% to 7.7%)1.2% (0.6% to 2.4%)<0.001
 90-day mortality8 cases6.8% (5.4% to 8.4%)10.8% (8.3% to 13.8%)3.4% (2.2% to 5.2%)<0.001
 Re-interventionNo curve23.6% (21.1% to 26.8%)NANANA
  • Emergency intervention was defined as an acute emergency operation or endoscopic stent insertion performed within 14 days of the primary EMR procedure.

  • Re-intervention was defined as repeat EMR, oesophagectomy or gastrectomy for the treatment of cancer at least 30 days following the initial EMR procedure.

  • EMR, endoscopic mucosal resection; RA-CUSUM, risk-adjusted cumulative sum.